| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |